Project Grant R43HL179154
- This Project Grant award, totaling $306,789, was provided by the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health federal grant program (CFDA 93.113). The grant aims to develop an at-home lateral flow assay (LFA) system for rapid, low-cost detection of per- and polyfluoroalkyl substances (PFAS) in water samples. The innovative approach integrates a magnetic nanoparticle pre-concentration method to achieve the sensitivity required by EPA standards, down...
- This $313,372 federal Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health program (CFDA 93.113) supports the development of an environmental sensor for the detection of per- and polyfluoroalkyl substances (PFAS). PFAS are a class of "forever chemicals" that have widespread contamination in the environment and pose significant human health risks. The funding will enable the awardee, Pearlhill Technologies LLC, to...
- This Project Grant award from the National Institute of Environmental Health Sciences (NIEHS), under the Environmental Health federal grant program (CFDA 93.113), will support Framergy, Inc., in collaboration with Texas A&M University, to develop a simple and low-cost method for detecting a broad range of per- and polyfluoroalkyl substances (PFAS) that can be used as an at-home test kit. The $260,993 award, granted on June 1, 2025, will fund research to leverage novel metal-organic framework...
- This federal Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) in the amount of $293,395 provides funding to the University of Connecticut Health Center to conduct research on democratizing access to effective air purification devices to reduce particulate air pollution (PM2.5) exposure and prevent adverse health outcomes. The project involves three main activities: 1) conducting focus groups and interviews to refine the...
- This federal Project Grant award from the National Institute of Environmental Health Sciences (NIEHS), under the Environmental Health Federal Grant Program (CFDA 93.113), is supporting research to investigate the long-term metabolic, vascular, and bone health effects of prenatal exposure to per- and polyfluoroalkyl substances (PFAS) mixtures. The $463,850 award to Brown University will leverage the New England Family Study (NEFS) cohort to measure PFAS concentrations in stored pregnancy and...
- The National Institute of Environmental Health Sciences (NIEHS) awarded a $390,337 Project Grant under the Environmental Health Federal Grant Program (CFDA 93.113) to the Icahn School of Medicine at Mount Sinai to develop the PFAS Exposure Burden Calculator. This novel tool will enable cross-study harmonization, biomonitoring, and report-back for per- and polyfluoroalkyl substances (PFAS) exposure levels. The project, which runs from Jul 2025 to May 2030, will expand the existing PFAS exposure...
- The National Institute of Environmental Health Sciences (NIEHS) awarded Wayne State University a 3-year, $1,644,161 Project Grant under the Environmental Health program (CFDA 93.113) to study the effects of per- and polyfluoroalkyl substances (PFAS) on atherosclerosis and cholesterol metabolism. The project aims to determine if PFAS mixtures accelerate atherosclerosis in a mouse model, assess how PFAS disrupts bile acid reuptake and leads to increased cholesterol levels, and evaluate the...
- This $165,364 federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to integrate novel contextual and genomic blood pressure measures to enhance cardiovascular disease prediction and management in young adults aged 18-39 years. The key products and services to be delivered under this 2-year award include: Identifying novel ambulatory blood pressure patterns that capture dynamic responses to everyday factors and...
- This federal Project Grant award of $660,283.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by Carnegie Mellon University to develop a high-throughput bioanalytical and machine learning approach for prioritizing bioaccumulative per- and polyfluoroalkyl substances (PFAS) in complex mixtures. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing...
- This $416,750 Project Grant award from the National Institute of Environmental Health Sciences (NIEHS), under the Environmental Health federal grant program (CFDA 93.113), will fund research at East Tennessee State University (ETSU) to investigate the effects of per- and polyfluoroalkyl substances (PFAS) on renal hemodynamics and kidney disease. The overarching goal is to determine if PFAS cause renal vasoconstriction, hypertension, and acute kidney injury, which can lead to chronic kidney...
This federal Project Grant award of $306,871 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to develop an educational and actionable report-back system for individuals and healthcare providers (HCPs) to help reduce PFAS (per- and polyfluoroalkyl substances) exposure and improve cardiovascular health in rural communities. The award recipient, Million Marker Wellness Inc., will work with 20 individuals and 10 HCPs in rural Nevada to create a personalized PFAS blood test report-back that provides guidance on minimizing PFAS exposure and monitoring related health conditions. This project seeks to address health disparities by empowering rural residents, particularly those in marginalized communities, to better understand and mitigate their PFAS exposure through an accessible, scalable biomonitoring tool for the patient-HCP setting.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $306.9k | 8/28/25 |